ConductScience.org, home
Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control
API referenceFor AI assistants

Trial · NCT03242252

Adverse events375

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

161 to 180 of 375

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousCoronary artery stenosisCardiac disordersSotagliflozin 200 mg0267
seriousCoronary artery stenosisCardiac disordersSotagliflozin 400 mg0260
seriousMyocardial infarctionCardiac disordersPlacebo1260
seriousMyocardial infarctionCardiac disordersSotagliflozin 200 mg1267
seriousMyocardial infarctionCardiac disordersSotagliflozin 400 mg3260
seriousMyocardial ischaemiaCardiac disordersPlacebo0260
seriousMyocardial ischaemiaCardiac disordersSotagliflozin 200 mg1267
seriousMyocardial ischaemiaCardiac disordersSotagliflozin 400 mg0260
seriousPericarditisCardiac disordersPlacebo0260
seriousPericarditisCardiac disordersSotagliflozin 200 mg0267
seriousPericarditisCardiac disordersSotagliflozin 400 mg1260
seriousAtelectasisRespiratory, thoracic and mediastinal disordersPlacebo1260
seriousAtelectasisRespiratory, thoracic and mediastinal disordersSotagliflozin 200 mg0267
seriousAtelectasisRespiratory, thoracic and mediastinal disordersSotagliflozin 400 mg0260
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersPlacebo0260
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersSotagliflozin 200 mg1267
seriousChronic obstructive pulmonary diseaseRespiratory, thoracic and mediastinal disordersSotagliflozin 400 mg0260
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersPlacebo0260
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersSotagliflozin 200 mg0267
seriousDyspnoeaRespiratory, thoracic and mediastinal disordersSotagliflozin 400 mg1260

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03242252/events?page=9

API referenceFor AI assistants